Return to homepagePandemic Pact

Development of COVID-19 antibody drug

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    RIKEN

  • Principal Investigator

    N/A

  • Research Location

    Japan

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Toward the development of antibody treatment against COVID-19, we are aiming to isolate a human monoclonal neutralizing antibody against SARS-CoV-2.